Need for newer pillars of therapy for reno-protection: pronounced eGFR slope improvement by SGLT2i and GLP-1RA in people with rapid eGFR decline

被引：0
|
作者：
Kashima, K. [1 ]
Shimizu, H. [2 ]
机构：
[1] Kiryu Kosei Gen Hosp, Kiryu, Japan
[2] Maebashi Hirosegawa Clin, Maebashi, Japan
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
882
引用
收藏
页码：S453 / S453
页数：1
相关论文
共 12 条
  • [1] Real-world effectiveness of adding newer generation GLP-1RA to SGLT2i in type 2 diabetes
    Nathorn Chaiyakunapruk
    Xi Tan
    Yuanjie Liang
    Mico Guevarra
    Lin Xie
    Alice Y. Y. Cheng
    Cardiovascular Diabetology, 24 (1)
  • [2] The Difference in the Effects on Microalbuminuria Depending on the Order of GLP-1RA and SGLT2i Therapy in Type 2 Diabetes
    Ohara, Masaya
    Motoyama, Koka
    Tamai, Anna
    Sakura, Takeshi
    Yakushiji, Yosuke
    Hosoi, Masayuki
    DIABETES, 2019, 68
  • [3] Restoration of blood vessel regeneration in the era of combination SGLT2i and GLP-1RA therapy for diabetes and obesity
    Terenzi, Daniella C.
    Bakbak, Ehab
    Teoh, Hwee
    Krishnaraj, Aishwarya
    Puar, Pankaj
    Rotstein, Ori D.
    Cosentino, Francesco
    Goldenberg, Ronald M.
    Verma, Subodh
    Hess, David A.
    CARDIOVASCULAR RESEARCH, 2024, 119 (18) : 2858 - 2874
  • [4] Genetic Mimics of GLP-1Ra and SGLT2i Therapy, Heart Failure and Chronic Kidney Disease Outcomes
    Remala, Subbaramireddy
    Liang, Liming
    Shah, Amil
    Buckley, Leo
    CIRCULATION, 2024, 150
  • [5] Glycaemic control and beta cell function in type 2 diabetes on SGLT2i and GLP-1RA combination therapy
    Martinez, R.
    Al-Jobory, H.
    Adams, J.
    Chavez-Velasquez, A.
    Triplitt, C.
    DeFronzo, R. A.
    Cersosimo, E.
    DIABETOLOGIA, 2017, 60 : S408 - S409
  • [6] SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study
    Anson, Matthew
    Zhao, Sizheng S.
    Austin, Philip
    Ibarburu, Gema H.
    Malik, Rayaz A.
    Alam, Uazman
    DIABETOLOGIA, 2023, 66 (10) : 1869 - 1881
  • [7] SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study
    Matthew Anson
    Sizheng S. Zhao
    Philip Austin
    Gema H. Ibarburu
    Rayaz A. Malik
    Uazman Alam
    Diabetologia, 2023, 66 : 1869 - 1881
  • [8] Combined therapy with SGLT2i and GLP-1ra improves cardiovascular prognosis in a population with diabetes and overweigh or obesity. A real-world clinical practice study
    Garcia Vega, D.
    Cinza-Sanjurjo, S.
    Gonzalez-Juanatey, J. R.
    Eiras, S.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [9] Effects of the launches of GLP-1 RA and SGLT2i and calendar year on yearly change in eGFR: results from an analysis of 48,363 person-years
    Katoh, S.
    Watanabe, Y.
    Yokoyama, K.
    Sakamoto, Y.
    Utsunomiya, K.
    Nishimura, R.
    DIABETOLOGIA, 2024, 67 : S434 - S434
  • [10] Effect of Combination SGLT2i and GLP-1RA Therapy on Glycemic Control, Body Weight, and Beta-Cell Function in Type 2 Diabetic (T2D) Subjects
    Martinez, Robert A.
    Al-Gburi, Karrar
    Al Jobori, Hussein
    Adams, John
    Abdul-Ghani, Muhammad
    Triplitt, Curtis
    Defronzo, Ralph A.
    Cersosimo, Eugenio
    DIABETES, 2017, 66 : LB44 - LB44
12